Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.52 |
| ▸ | LDHA | P00338 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29401627 | 0.87 | PTPN22 (0.65) | POLBPTPN22LDHAHSD17B10ALDH1A1 | |
| SCHEMBL374807 | 0.87 | PTPN22 (0.65) | POLBPTPN22LDHAHSD17B10ALDH1A1 | |
| SCHEMBL9060860 | 0.85 | PTPN22 (0.62) | POLBPTPN22LDHAHSD17B10ALDH1A1 | |
| SCHEMBL5155985 | 0.85 | PTPN22 (0.62) | POLBPTPN22LDHAHSD17B10ALDH1A1 | |
| SCHEMBL1840828 | 0.85 | PTPN22 (0.62) | POLBPTPN22LDHAHSD17B10ALDH1A1 | |
| SCHEMBL9510182 | 0.83 | PTPN22 (0.56) | POLBPTPN22LDHAHSD17B10ALDH1A1 | |
| SCHEMBL19543873 | 0.82 | ALDH1A1 (0.51) | POLBPTPN22LDHAHSD17B10ALDH1A1 | |
| SCHEMBL17726752 | 0.82 | PTPN22 (0.50) | POLBPTPN22LDHAHSD17B10ALDH1A1 | |
| SCHEMBL6634384 | 0.81 | PTPN22 (0.58) | POLBPTPN22LDHAHSD17B10ALDH1A1 | |
| SCHEMBL8735056 | 0.81 | PTPN22 (0.58) | PTPN22LDHAHSD17B10ALDH1A1CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11380846-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2022-07-05 | — | — | US | disclosed |
| EP-3305773-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREFOR | Duk San Neolux Co., Ltd. (KR) | 2018-04-11 | — | — | EP | disclosed |
| EP-3305773-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREFOR | Duk San Neolux Co., Ltd. (KR) | 2018-04-11 | — | — | EP | disclosed |
| US-20180083197-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-03-22 | — | — | US | disclosed |
| US-20180083197-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-03-22 | — | — | US | disclosed |
| CN-107667098-A | Organic electric element compound, organic electric element and its electronic installation using it | 德山新勒克斯有限公司 | 2018-02-06 | — | — | CN | disclosed |
| WO-2016190600-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREFOR | 덕산네오룩스 주식회사 | 2016-12-01 | — | — | WO | disclosed |
| WO-2016190600-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREFOR | 덕산네오룩스 주식회사 | 2016-12-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11380846-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | PIEZO1, OCIAD1, LEF1 | POLB 1775/4885PTPN22 3441/4885LDHA 886/4885 |
| US-20180083197-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | PIEZO1, OCIAD1, LEF1 | POLB 1775/4885PTPN22 3441/4885LDHA 886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.